ONL Therapeutics raised $65M in Series D funding led by Johnson & Johnson Innovation to expand development efforts for treatments of geographic atrophy associated with dry age-related macular degeneration.
Amount Raised
$65 Million
Round Type
Series D
Ann ArborBiotechnologyHealth CareBiopharmaInvestors
Description
ONL Therapeutics, based in Ann Arbor, MI, has closed a $65M Series D financing round. The funds will be used to enhance their clinical program focused on vision protection and improvement in patients suffering from retinal disease.
Quick answer
ONL Therapeutics raised $65 Million in a Series D round, dated September 16, 2024. Investors: Visionary Ventures, Novartis Venture Fund, Bios Partners and Johnson & Johnson Innovation. ONL Therapeutics is based in Ann Arbor, Michigan, United States.
- How much did ONL Therapeutics raise?
- ONL Therapeutics raised $65 Million in a Series D round on September 16, 2024.
- Who invested in ONL Therapeutics?
- Visionary Ventures, Novartis Venture Fund, Bios Partners and Johnson & Johnson Innovation are named as investors in this round.
- What does ONL Therapeutics do?
- ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease.
- Where is ONL Therapeutics based and how big is it?
- ONL Therapeutics is based in Ann Arbor, Michigan, United States. Fundz records about 10 employees.
- Who are the decision-makers at ONL Therapeutics?
- Fundz holds 1 contact at ONL Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biopharma and Biotechnology around the same time
Companies in the same sectors as ONL Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Tempero Bio raised $77M on October 30, 2024.
- Ensho Therapeutics raised $5M on October 24, 2024.
- LaNova Medicines raised $41M (Series C) on October 18, 2024.
- Vicebio Ltd raised $100M (Series B) on September 23, 2024.
- Summit Therapeutics raised $235M on September 11, 2024.
- Cumulus Oncology raised $50M (Series A) on September 3, 2024.
Who to call at ONL Therapeutics, and when
A new round usually means ONL Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ONL Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ONL Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ONL Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ONL Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ONL Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.